Opposite Roles of Tra2β and SRSF9 in the v10 Exon Splicing of CD44.

CD44 SRSF9 Tra2β alternative splicing v10

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
30 Oct 2020
Historique:
received: 01 09 2020
revised: 09 10 2020
accepted: 14 10 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 5 11 2020
Statut: epublish

Résumé

CD44 is a transmembrane glycoprotein involved in cell-cell and cell-matrix interactions. Several CD44 protein isoforms are generated in human through alternative splicing regulation of nine variable exons encoding for the extracellular juxta-membrane region. While the CD44 splicing variants have been described to be involved in cancer progression and development, the regulatory mechanism(s) underlying their production remain unclear. Here, we identify Tra2β and SRSF9 as proteins with opposite roles in regulating CD44 exon v10 splicing. While Tra2β promotes v10 inclusion, SRSF9 inhibits its inclusion. Mechanistically, we found that both proteins are able to target v10 exon, with GAAGAAG sequence being the binding site for Tra2β and AAGAC that for SRSF9. Collectively, our data add a novel layer of complexity to the sequential series of events involved in the regulation of CD44 splicing.

Identifiants

pubmed: 33143085
pii: cancers12113195
doi: 10.3390/cancers12113195
pmc: PMC7692347
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Education and the National Research Foundation of Korea
ID : 2020R1A2C2004682
Organisme : the Ministry of Education and the National Research Foundation of Korea
ID : 2019R1I1A1A01057372
Organisme : the Ministry of Education and the National Research Foundation of Korea
ID : 2016R1A5A1007318
Organisme : GIST Research Institute (GRI) IIBR" grant funded by the GIST
ID : 2020

Références

PLoS One. 2014 Feb 19;9(2):e88712
pubmed: 24586375
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Cell. 2006 Jul 14;126(1):37-47
pubmed: 16839875
Hum Mol Genet. 2005 Aug 15;14(16):2289-303
pubmed: 16000324
EMBO Mol Med. 2013 May;5(5):737-50
pubmed: 23592547
Nat Struct Mol Biol. 2011 Apr;18(4):443-50
pubmed: 21399644
RNA. 2016 Sep;22(9):1285-301
pubmed: 27530828
Mol Cell Biol. 2002 Jun;22(12):4001-10
pubmed: 12024014
Front Oncol. 2016 Jun 20;6:145
pubmed: 27379207
J Invest Dermatol. 2000 Oct;115(4):653-7
pubmed: 10998138
Science. 1991 May 10;252(5007):833-6
pubmed: 1902987
J Leukoc Biol. 2007 Jul;82(1):57-71
pubmed: 17442857
RNA. 2000 Sep;6(9):1197-211
pubmed: 10999598
Biochim Biophys Acta. 2015 Jun;1849(6):743-50
pubmed: 25623890
Hum Mol Genet. 2002 Mar 1;11(5):577-87
pubmed: 11875052
Cancer Sci. 2016 Feb;107(2):123-32
pubmed: 26663681
Semin Cell Dev Biol. 2014 Aug;32:30-6
pubmed: 24657195
Mol Cancer. 2017 Jan 30;16(1):8
pubmed: 28137272
Cancer Sci. 2018 Feb;109(2):289-296
pubmed: 29161765
Hum Mutat. 2012 Jan;33(1):81-5
pubmed: 21922594
Biochem J. 2009 Jan 1;417(1):15-27
pubmed: 19061484
Nat Commun. 2012 Jun 06;3:883
pubmed: 22673910
Nat Rev Clin Oncol. 2020 Aug;17(8):457-474
pubmed: 32303702
Annu Rev Biochem. 2003;72:291-336
pubmed: 12626338
Nature. 2007 Apr 19;446(7138):926-9
pubmed: 17361132
Biochem J. 2016 Oct 1;473(19):3013-30
pubmed: 27458252
Genes Dev. 2014 Jun 1;28(11):1191-203
pubmed: 24840202
Biochim Biophys Acta. 2014 Jan;1839(1):25-32
pubmed: 24321384
Oncol Rep. 2014 Jan;31(1):273-9
pubmed: 24173428
Cell Rep. 2019 Nov 26;29(9):2672-2688.e7
pubmed: 31775037
Dev Biol. 1983 Feb;95(2):512-7
pubmed: 6402401
Nature. 1987 Feb 19-25;325(6106):673-8
pubmed: 2950324
Mol Cell Biol. 2006 Jan;26(1):362-70
pubmed: 16354706
J Biol Chem. 1993 Jun 15;268(17):12235-8
pubmed: 8509359
J Clin Invest. 2011 Mar;121(3):1064-74
pubmed: 21393860
Hum Genet. 2017 Sep;136(9):1143-1154
pubmed: 28382513
Nucleic Acids Res. 2011 Mar;39(4):1538-53
pubmed: 20926394
Genet Eng (N Y). 1990;12:201-24
pubmed: 1368558
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W361-7
pubmed: 24829458
Cell Signal. 2014 Oct;26(10):2234-9
pubmed: 25025570
Annu Rev Genet. 1986;20:671-708
pubmed: 2880558
J Cell Physiol. 1995 Jan;162(1):127-33
pubmed: 7529235
Exp Hematol. 1999 Apr;27(4):698-711
pubmed: 10210328
Jpn J Cancer Res. 1995 Sep;86(9):847-53
pubmed: 7591962
J Biol Chem. 2008 Aug 1;283(31):21315-24
pubmed: 18534987
J Cell Physiol. 2001 Oct;189(1):54-63
pubmed: 11573204
Nucleic Acids Res. 2011 Oct;39(18):8092-104
pubmed: 21724598
Genes Dev. 2019 Feb 1;33(3-4):166-179
pubmed: 30692202

Auteurs

Jagyeong Oh (J)

School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

Yongchao Liu (Y)

School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

Namjeong Choi (N)

School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

Jiyeon Ha (J)

School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

Davide Pradella (D)

Istituto di Genetica Molecolare Luigi Luca Cavalli Sforza-Consiglio Nazionale delle Ricerche Via Abbiategrasso 207, 27100 Pavia, Italy.

Claudia Ghigna (C)

Istituto di Genetica Molecolare Luigi Luca Cavalli Sforza-Consiglio Nazionale delle Ricerche Via Abbiategrasso 207, 27100 Pavia, Italy.

Xuexiu Zheng (X)

School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

Haihong Shen (H)

School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

Classifications MeSH